Bio Laboratories Limited - Filleted accounts

Registered number

03258130

Bio Laboratories Limited

Filleted Accounts

31 December 2025

Bio Laboratories Limited
Registered number:		03258130
Balance Sheet
as at 31 December 2025

Notes			2025			2024
£				£
Fixed assets
Tangible assets	3		1,188			2,120

Current assets
Stocks		930,491			897,412
Debtors	4	1,277,334			1,810,937
Cash at bank and in hand		27,005			43,637
		2,234,830			2,751,986

Creditors: amounts falling due within one year	5	(1,248,541)			(1,700,828)

Net current assets			986,289			1,051,158

Total assets less current liabilities			987,477			1,053,278


Provisions for liabilities			(226)			(281)


Net assets			987,251			1,052,997

Capital and reserves
Called up share capital			40,000			40,000
Profit and loss account			947,251			1,012,997

Shareholders' funds			987,251			1,052,997

The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.




Ian Richard Webb
Director
Approved by the board on 26 August 2026

Bio Laboratories Limited
Notes to the Accounts
for the year ended 31 December 2025


1	Accounting policies

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Tangible fixed assets
	Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:

	Fixtures, fittings, tools and equipment	25% written down value

	Stocks
	Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.

	Debtors
	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts.

	Creditors
	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference. Current and deferred tax assets and liabilities are not discounted.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Leased assets
	A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership. All other leases are classified as operating leases. The rights of use and obligations under finance leases are initially recognised as assets and liabilities at amounts equal to the fair value of the leased assets or, if lower, the present value of the minimum lease payments. Minimum lease payments are apportioned between the finance charge and the reduction in the outstanding liability using the effective interest rate method. The finance charge is allocated to each period during the lease so as to produce a constant periodic rate of interest on the remaining balance of the liability. Leased assets are depreciated in accordance with the company's policy for tangible fixed assets. If there is no reasonable certainty that ownership will be obtained at the end of the lease term, the asset is depreciated over the lower of the lease term and its useful life. Operating lease payments are recognised as an expense on a straight line basis over the lease term.

	Pensions
	Contributions to defined contribution plans are expensed in the period to which they relate.


2	Employees		2025		2024
Number				Number

	Average number of persons employed by the company		14		15


3	Tangible fixed assets
					Plant and machinery etc
£
	Cost
	At 1 January 2025				55,373
	At 31 December 2025				55,373

	Depreciation
	At 1 January 2025				53,253
	Charge for the year				932
	At 31 December 2025				54,185

	Net book value
	At 31 December 2025				1,188
	At 31 December 2024				2,120


4	Debtors		2025		2024
£				£

	Trade debtors		1,200,543		1,750,443
	Other debtors		76,791		60,494
			1,277,334		1,810,937


5	Creditors: amounts falling due within one year		2025		2024
£				£

	Trade creditors		763,690		1,174,565
	Taxation and social security costs		50,015		72,021
	Other creditors		434,836		454,242
			1,248,541		1,700,828


6	Financial Instruments

	The company has entered into a non-recourse discounting agreement with Santander UK plc for a total of £360,818 (2024 - £388,237) of trade receivables. The invoice discounted receivables have reduced trade debtors on the balance sheet, and the proceeds have been recognized as cash received. Charges of £23,760 (2024 - £27,987) for the year are recognized as an expense in the income statement within bank charges. The company has no recourse obligations under this agreement. There is a charge registered with Companies House over freehold and leasehold property owned by the company.


7	Related party transactions
			2025		2024
	Perfumes-4U Limited
	Ian Webb and Lorraine Rowland, directors and shareholders of this company are also directors of Perfumes-4U Limited
	During the year Bio Laboratories Limited sold goods to Perfumes-4U Limited, excluding VAT of		16,418		25,345
	Charge in relation to services provided to Bio Laboratories Limited by Perfumes-4U Limited		3,000		3,025
	Amount owed by Perfumes-4U Limited at year end		5,026		3,208

8	Other information

	Bio Laboratories Limited is a private company limited by shares and incorporated in England. Its registered office is:
	Unit 1, Atlas Point
	Davenport Lane
	Broadheath
	Altrincham
	WA14 5DT